Michael Celano
Chief Financial Officer · Larimar Therapeutics, Inc.
Individual
- 2026
- Jan 27, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael Celano files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- James E. Flynn - $25.00M in LRMR purchases and sales in the last 12 months
- Thomas Edward Hamilton - $667K in LRMR purchases and sales in the last 12 months
- Jeffrey W. Sherman - $25K in LRMR purchases and sales in the last 12 months
- Frank E. Thomas - $25K in LRMR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael Celano?
Michael Celano is a corporate insider, tracked as Chief Financial Officer of Larimar Therapeutics, Inc. (LRMR). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Michael Celano last file a Form 4?
The only primary Form 4 on record is dated 27 January 2026.
